Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial. [electronic resource]
Producer: 20190110Description: 523-528 p. digitalISSN:- 1532-866X
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.